Skip to content

Current Topics in Behavioral Neurosciences

ISSN 1866-3370, 1866-3389

71 papers in the library · 1,692 citations · publishing 2015-2026

Papers

Sort Most recent Most cited

Therapeutic Applications of Classic Hallucinogens.

Current Topics in Behavioral Neurosciences 2018 Michael P. Bogenschutz, Stephen Ross 84 citations

This chapter reviews what is known about the therapeutic uses of the serotonergic or classic hallucinogens, i.e., psychoactive drugs such as LSD and psilocybin that exert their effects primarily through agonist activity at serotonin 2A (5HT2A) receptors. Following a review of the history of human use and scientific study of these drugs, the data from clinical research are summarized, including...

DOI: 10.1007/7854_2016_464 (opens in new tab) Psychological therapy Behavioral health solutions Mental healthcare Emerging therapies +9

New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca.

Current Topics in Behavioral Neurosciences 2018 Dennis J. Mckenna, Jordi Riba 67 citations

New World indigenous peoples are noted for their sophisticated use of psychedelic plants in shamanic and ethnomedical practices. The use of psychedelic plant preparations among New World tribes is far more prevalent than in the Old World. Yet, although these preparations are botanically diverse, almost all are chemically similar in that their active principles are tryptamine derivatives, either...

DOI: 10.1007/7854_2016_472 (opens in new tab) Consciousness studies Ayahuasca research Amazonian brew Tryptamine compounds +14

Effects of Hallucinogens on Neuronal Activity.

Current Topics in Behavioral Neurosciences 2018 Laia Lladó-Pelfort, Pau Celada, Maurizio S Riga et al. 18 citations

Hallucinogens evoke sensory, perceptual, affective, and cognitive effects that may be useful to understand the neurobiological basis of mood and psychotic disorders. The present chapter reviews preclinical research carried out in recent years in order to better understand the action of psychotomimetic agents such as the noncompetitive NMDA receptor (NMDA-R) antagonists and serotonergic...

DOI: 10.1007/7854_2017_473 (opens in new tab) Full text (opens in new tab) 5-ht2a receptors Antipsychotic drugs Nmda receptors Prefrontal cortex +1

The Discriminative Stimulus Properties of Hallucinogenic and Dissociative Anesthetic Drugs.

Current Topics in Behavioral Neurosciences 2018 Tomohisa Mori, Tsutomu Suzuki

The subjective effects of drugs are related to the kinds of feelings they produce, such as euphoria or dysphoria. One of the methods that can be used to study these effects is the drug discrimination procedure. Many researchers have been trying to elucidate the mechanisms that underlie the discriminative stimulus properties of abused drugs (e.g., alcohol, psychostimulants, and opioids). Over...

DOI: 10.1007/7854_2016_29 (opens in new tab) Full text (opens in new tab) Serotonin Discriminative stimulus properties Hallucinogens Psychedelics +1

Discriminative Stimulus Properties of Phytocannabinoids, Endocannabinoids, and Synthetic Cannabinoids.

Current Topics in Behavioral Neurosciences 2018 Jenny L Wiley, R Allen Owens, Aron H Lichtman

Psychoactive cannabinoids from the marijuana plant (phytocannabinoids), from the body (endocannabinoids), and from the research lab (synthetic cannabinoids) produce their discriminative stimulus effects by stimulation of CB1 receptors in the brain. Early discrimination work with phytocannabinoids confirmed that Δ9-tetrahydrocannabinol (Δ9-THC) is the primary psychoactive constituent of the...

DOI: 10.1007/7854_2016_24 (opens in new tab) Full text (opens in new tab) 2-arachidonoylglycerol Anandamide Endocannabinoids Faah inhibitors +3

The Effects of Hallucinogens on Gene Expression.

Current Topics in Behavioral Neurosciences 2018 David Martin, Charles D. Nichols

The classic serotonergic hallucinogens, or psychedelics, have the ability to profoundly alter perception and behavior. These can include visual distortions, hallucinations, detachment from reality, and mystical experiences. Some psychedelics, like LSD, are able to produce these effects with remarkably low doses of drug. Others, like psilocybin, have recently been demonstrated to have...

Serotonergic Hallucinogen-Induced Visual Perceptual Alterations.

Current Topics in Behavioral Neurosciences 2018 Michael Kometer, Franz X. Vollenweider

Serotonergic hallucinogens, such as lysergic acid diethylamide (LSD), psilocybin, and N,N-dimethyltryptamine (DMT), are famous for their capacity to temporally and profoundly alter an individual's visual experiences. These visual alterations show consistent attributes despite large inter- and intra-individual variances. Many reports document a common perception of colors as more saturated, with...

Human Drug Discrimination: Elucidating the Neuropharmacology of Commonly Abused Illicit Drugs.

Current Topics in Behavioral Neurosciences 2018 B Levi Bolin, Joseph L Alcorn, Anna R Reynolds et al.

Drug-discrimination procedures empirically evaluate the control that internal drug states have over behavior. They provide a highly selective method to investigate the neuropharmacological underpinnings of the interoceptive effects of drugs in vivo. As a result, drug discrimination has been one of the most widely used assays in the field of behavioral pharmacology. Drug-discrimination...

A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD.

Current Topics in Behavioral Neurosciences 2018 John H. Halpern, Arturo G Lerner, Torsten Passie

Hallucinogen persisting perception disorder (HPPD) is rarely encountered in clinical settings. It is described as a re-experiencing of some perceptual distortions induced while intoxicated and suggested to subsequently cause functional impairment or anxiety. Two forms exist: Type 1, which are brief "flashbacks," and Type 2 claimed to be chronic, waxing, and waning over months to years. A review...

DOI: 10.1007/7854_2016_457 (opens in new tab) Full text (opens in new tab) LSD Dissociation Drug-induced flashback Hallucinogens

Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways

Current Topics in Behavioral Neurosciences 2017 Juan F López-Giménez, Javier González-Maeso 302 citations

The neuropsychological effects of naturally occurring psychoactive chemicals have been recognized for millennia. Hallucinogens, which include naturally occurring chemicals such as mescaline and psilocybin, as well as synthetic compounds, such as lysergic acid diethylamide (LSD), induce profound alterations of human consciousness, emotion, and cognition. The discovery of the hallucinogenic...

Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.

Current Topics in Behavioral Neurosciences 2017 Adam L. Halberstadt 100 citations

Serotonergic hallucinogens induce profound changes in perception and cognition. The characteristic effects of hallucinogens are mediated by 5-HT2A receptor activation. One class of hallucinogens are 2,5-dimethoxy-substituted phenethylamines, such as the so-called 2C-X compounds 2,5-dimethoxy-4-bromophenethylamine (2C-B) and 2,5-dimethoxy-4-iodophenethylamine (2C-I). Addition of an N-benzyl...

DOI: 10.1007/7854_2016_64 (opens in new tab) Full text (opens in new tab) Head twitch response Locomotor activity Psychedelic Research chemical +4

Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration.

Current Topics in Behavioral Neurosciences 2017 Shawn. M. Aarde, Michael A. Taffe

Animal models of drug self-administration are currently the gold standard for making predictions regarding the relative likelihood that a recreational drug substance will lead to continued use and addiction. Such models have been found to have high predictive accuracy and discriminative validity for a number of drug classes including ethanol, nicotine, opioids, and psychostimulants such as...

Combination Chemistry: Structure-Activity Relationships of Novel Psychoactive Cannabinoids.

Current Topics in Behavioral Neurosciences 2017 Jenny L Wiley, Julie A. Marusich, Brian F Thomas

Originally developed as research tools for use in structure-activity relationship studies, synthetic cannabinoids contributed to significant scientific advances in the cannabinoid field. Unfortunately, a subset of these compounds was diverted for recreational use beginning in the early 2000s. As these compounds were banned, they were replaced with additional synthetic cannabinoids with...

Interactions of Cathinone NPS with Human Transporters and Receptors in Transfected Cells.

Current Topics in Behavioral Neurosciences 2017 Linda D. Simmler, Matthias E. Liechti

Pharmacological assays carried out in transfected cells have been very useful for describing the mechanism of action of cathinone new psychoactive substances (NPS). These in vitro characterizations provide fast and reliable information on psychoactive substances soon after they emerge for recreational use. Well-investigated comparator compounds, such as methamphetamine,...

DOI: 10.1007/7854_2016_20 (opens in new tab) Full text (opens in new tab) Cathinones Efflux Heterologous expression systems In vitro +4

Contribution of Impulsivity and Serotonin Receptor Neuroadaptations to the Development of an MDMA ('Ecstasy') Substance Use Disorder.

Current Topics in Behavioral Neurosciences 2017 Susan Schenk, Dane Aronsen

As is the case with other drugs of abuse, a proportion of ecstasy users develop symptoms consistent with a substance use disorder (SUD). In this paper, we propose that the pharmacology of MDMA, the primary psychoactive component of ecstasy tablets, changes markedly with repeated exposure and that neuroadaptations in dopamine and serotonin brain systems underlie the shift from MDMA use to MDMA...

Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites

Current Topics in Behavioral Neurosciences 2017 S. Tai, William E Fantegrossi

Commercial preparations containing synthetic cannabinoids (SCBs) are rapidly emerging as drugs of abuse. Although often assumed to be “safe” and “legal” alternatives to cannabis, reports indicate that SCBs induce toxicity not often associated with the primary psychoactive component of marijuana, Δ9-tetrahydrocannabinol (Δ9-THC). This chapter will summarize the evidence that use of SCBs poses...

MDMA, Methylone, and MDPV: Drug-Induced Brain Hyperthermia and Its Modulation by Activity State and Environment.

Current Topics in Behavioral Neurosciences 2017 Eugene A. Kiyatkin, Suelynn E Ren

Psychomotor stimulants are frequently used by humans to intensify the subjective experience of different types of social interactions. Since psychomotor stimulants enhance metabolism and increase body temperatures, their use under conditions of physiological activation and in warm humid environments could result in pathological hyperthermia, a life-threatening symptom of acute drug...

NPS: Medical Consequences Associated with Their Intake.

Current Topics in Behavioral Neurosciences 2017 Fabrizio Schifano, Laura Orsolini, Duccio Papanti et al.

Over the last decade, the 'traditional' drug scene has been supplemented - but not replaced - by the emergence of a range of novel psychoactive substances (NPS), which are either newly created or existing drugs, including medications, now being used in novel ways. By the end of 2014, in excess of 500 NPS had been reported by a large number of countries in the world. Most recent data show,...

DOI: 10.1007/7854_2016_15 (opens in new tab) Full text (opens in new tab) Drug misuse Hallucinogenic drugs Hallucinogens Novel psychoactive substances +4

Phenomenology, Structure, and Dynamic of Psychedelic States

Current Topics in Behavioral Neurosciences 2016 Katrin H. Preller, Franz X. Vollenweider 285 citations

Classic serotonergic hallucinogens or psychedelics produce an altered states of consciousness (ASC) that is characterized by profound alterations in sensory perception, mood, thought including the perception of reality, and the sense of self. Over the past years, there has been considerable progress in the search for invariant and common features of psychedelic states. In the first part of this...

Effect of Hallucinogens on Unconditioned Behavior

Current Topics in Behavioral Neurosciences 2016 Mark A. Geyer, Adam L. Halberstadt 104 citations

Because of the ethical and regulatory hurdles associated with human studies, much of what is known about the psychopharmacology of hallucinogens has been derived from animal models. However, developing reliable animal models has proven to be a challenging task due to the complexity and variability of hallucinogen effects in humans. This chapter focuses on three animal models that are frequently...

DOI: 10.1007/7854_2016_466 (opens in new tab) Full text (opens in new tab) Hallucinogens Psychedelics Psychoactive substances Animal models +9

New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca

Current Topics in Behavioral Neurosciences 2015 Dennis J. Mckenna, Jordi Riba 31 citations

New World indigenous peoples are noted for their sophisticated use of psychedelic plants in shamanic and ethnomedical practices. The use of psychedelic plant preparations among New World tribes is far more prevalent than in the Old World. Yet, although these preparations are botanically diverse, almost all are chemically similar in that their active principles are tryptamine derivatives, either...